Latest Breaking News On - Eli lilly asia inc - Page 1 : comparemela.com

Everest Medicines Appoints Kevin Guo as Chief Commercial Officer News provided by Share this article Share this article SHANGHAI, Feb. 18, 2021 /PRNewswire/ Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today the appointment of Kevin Guo as Chief Commercial Officer. Mr. Guo brings more than 22 years of commercial leadership and business management experience across a number of multinational pharmaceutical companies. Mr. Guo s successful track record of commercial planning and execution for global pharmaceutical companies and his strong cross-cultural leadership skills make him uniquely suited for this important executive position at Everest Medicines, said Kerry Blanchard, MD, PhD, chief executive officer of Everest Medicines. He will play a critical role in ushering Evere

Kerry blanchardChina europe international business schoolAmerican shanghai squibb pharmaceuticalEisai suzhou trading co ltdEli lilly asia incEisai china incFourth military universityPfizer incShanghai roche pharmaceutical ltdWyeth pharmaceuticals co ltdGreater chinaKevin guoChief commercialEverest medicinesOncology business unitChina europe international business